Newly launched pet health startup Gallant wants you to bank your dog’s stem cells for $990
With $11 million in funding and a mission to open up the doors of regenerative therapies to dogs across the nation, the Los Angeles-based startup Gallant is now opening its doors for the first time.
The company was founded by DogVacay founder and chief executive Aaron Hirschhorn after seeing his own pet’s struggle with debilitating illness and knowing firsthand that regenerative medicine and stem cell therapies could help.
“I struggled with debilitating chronic back pain for more than a decade, leaving me incapable of doing activities I loved, until regenerative medicine successfully cured my condition,” said Hirschhorn, in a statement. “At the same time, I watched my dog Rocky suffer from arthritis so painful that she couldn’t walk. I knew there had to be a better way to treat and heal our pets, which sparked the beginning of Gallant. We are on a mission to keep our pets happier and healthier through the power of regenerative medicine.”
Joining Hirschhorn at the company is Linda Black, an experienced serial entrepreneur at life sciences companies like Medicus Biosciences and SciStem, which both focused on developing regenerative therapies. Richard Jennings, the chief executive of cord blood banking company California Cryobank, and Darryl Rawlings,
This post was originally published on this site